Cargando…
Lung cancer immunotherapy: progress, pitfalls, and promises
Lung cancer is the primary cause of mortality in the United States and around the globe. Therapeutic options for lung cancer treatment include surgery, radiation therapy, chemotherapy, and targeted drug therapy. Medical management is often associated with the development of treatment resistance lead...
Autores principales: | Lahiri, Aritraa, Maji, Avik, Potdar, Pravin D., Singh, Navneet, Parikh, Purvish, Bisht, Bharti, Mukherjee, Anubhab, Paul, Manash K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942077/ https://www.ncbi.nlm.nih.gov/pubmed/36810079 http://dx.doi.org/10.1186/s12943-023-01740-y |
Ejemplares similares
-
Recent Progress in the Theranostics Application of Nanomedicine in Lung Cancer
por: Mukherjee, Anubhab, et al.
Publicado: (2019) -
Communication in non-communicable diseases (NCDs) and role of immunomodulatory nutraceuticals in their management
por: Kumar, Abhiram, et al.
Publicado: (2022) -
The Genetics of Sepsis: The Promise, the Progress and the Pitfalls
por: Waterer, Grant W.
Publicado: (2008) -
Recent Advancements of Nanomedicine towards Antiangiogenic Therapy in Cancer
por: Mukherjee, Anubhab, et al.
Publicado: (2020) -
Promise and pitfalls of the Immunochip
por: Cortes, Adrian, et al.
Publicado: (2011)